Nutex Health director granted 823 RSUs
Saunders Scott J reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Saunders Scott J reported acquisition or exercise transactions in this Form 4 filing.
Nutex Health Inc. director Scott J. Saunders received a grant of 823 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Nutex common stock upon vesting. These RSUs vest 100% on April 23, 2027, and will vest on a pro-rata basis if he leaves the company without cause before that date. Following this award, Saunders holds a total of 1,426 RSUs directly.
Insider Trade Summary
Grant/Award: 823 shares
Grant/Award
1 txn
Insider
Saunders Scott J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (RSUs) | 823 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units (RSUs) — 1,426 contracts (Direct)
Footnotes (2)
- F1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
- F2. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.
Key Figures
RSUs granted: 823 RSUs
RSUs outstanding after grant: 1,426 RSUs
Vesting date: April 23, 2027
+2 more
5 metrics
RSUs granted
823 RSUs
Grant to director Scott J. Saunders on April 23, 2026
RSUs outstanding after grant
1,426 RSUs
Total RSUs held by Scott J. Saunders following transaction
Vesting date
April 23, 2027
100% vesting date for the 823 RSUs
Underlying common stock per RSU
1 share per RSU
Each RSU converts into one Nutex common share upon vesting
Exercise/conversion price
$0.0000 per RSU
No cash exercise price; RSUs settle in shares upon vesting
Key Terms
Restricted Stock Units (RSUs), contingent right, par value, pro-rata basis
4 terms
Restricted Stock Units (RSUs) financial
"The Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
contingent right financial
"Each RSU represents a contingence right to receive one share of the issuer's common stock"
par value financial
"one share of the issuer's common stock, $0.001 par value, upon vesting"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
pro-rata basis financial
"the RSUs shall vest on a pro-rata basis for the actual time in service"
Allocation or distribution that gives each participant a share proportional to their existing ownership, stake or entitlement — like slicing a pie so everyone gets a piece matching how big their original slice was. For investors this matters because it determines how much of new shares, dividends, fees or obligations they receive, helps preserve or change ownership percentages, and directly affects dilution and voting power.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nutex Health (NUTX) director Scott Saunders report?
Director Scott J. Saunders reported receiving 823 Restricted Stock Units (RSUs) from Nutex Health as a grant. These RSUs are a form of equity compensation that can convert into common stock if specific vesting conditions are met over time.
When do Scott Saunders’ 823 Nutex Health (NUTX) RSUs vest?
The 823 RSUs granted to Scott Saunders vest 100% on April 23, 2027. Once vested, each RSU entitles him to receive one share of Nutex Health common stock, subject to the terms of the company’s equity compensation plan.
What happens to Scott Saunders’ Nutex Health RSUs if he leaves before vesting?
If Scott Saunders leaves Nutex Health without cause during the vesting period, his 823 RSUs will vest on a pro-rata basis. That means vesting will be adjusted to reflect the actual time he remained in service with the company before departure.
How many Nutex Health (NUTX) RSUs does Scott Saunders hold after this grant?
After receiving the new grant of 823 RSUs, Scott Saunders holds a total of 1,426 RSUs directly. Each RSU represents a contingent right to receive one share of Nutex Health common stock once the applicable vesting conditions are satisfied.
What does each Nutex Health RSU granted to Scott Saunders represent?
Each RSU granted to Scott Saunders represents a contingent right to receive one share of Nutex Health common stock with $0.001 par value. The shares are only delivered after the RSUs vest according to the specified schedule and employment conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates